Replies to post #6966 on Revance Therapeutics Inc (RVNC)

[Tomdontworry]

The valuation is getting a bit absurd… $300M+ cash vs $430M market cap. In theory china approval can come anytime starting next week and then you have catalysts ER and therapeutics launch. If Soma is credible and Daxi is gaining traction then plenty to look forward to.

[alertmeipp]

It's tough to be long. Few weeks ago, this was trading at $7.5.. .now almost dropped half... no new news.

Good news is we are closer to bottom whatever that is.

[edcoolidge]

I suspect between likely no rate cuts this year, a difficult balance sheet, a week Q1, and distrust of Foley, we will see RVNC in the $2's this year. Revance is priced for likely bankruptcy. They're hardly alone. Nobody wants to own unprofitable small caps with debt in this environment. Many of these companies will go bankrupt. If Revance doesn't then we will likely look back on the current share price as an excellent opportunity. The RVNCQ clowns on this board want to convince everyone that the share price collapse is proof Daxxify "doesn't work" or is inferior to other toxins. That's wrong.